Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-035768
Filing Date
2016-12-16
Accepted
2016-12-16 16:11:18
Documents
1
Period of Report
2016-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4285
  Complete submission text file 0000899243-16-035768.txt   5845
Mailing Address ADELPHI PLAZA, UPPER GEORGE?S STREET D?N LAOGHAIRE, CO. DUBLIN DUBLIN L2 A96 T927
Business Address ADELPHI PLAZA, UPPER GEORGE?S STREET D?N LAOGHAIRE, CO. DUBLIN DUBLIN L2 A96 T927 650-615-2119
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Karp Carol D. (Reporting) CIK: 0001692214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 162056429